Atellica® VTLi Patient-side Immunoassay Analyzer
A vital leap forward in cardiac testing
When a patient enters the emergency department presenting with the symptoms of a myocardial infarction (MI), every moment is critical. Achieving favorable clinical and operational outcomes requires fast and accurate chest pain assessment at the point of care, as well as coordination with the laboratory for quality assurance. Having high-sensitivity troponin testing at the point of care—producing accurate results in just 8 minutes—could transform care delivery for millions of people each year, improving ED throughput, reducing stress and strain on acute care clinicians, and aiding in optimizing the use of time and resources of busy laboratories.
Features & Benefits
Simple to use and easily integrated into existing systems, the Atellica® VTLi Patient-side Immunoassay Analyzer, powered by Magnotech® Technology, delivers accurate, clinically actionable high-sensitivity troponin I results directly in the hands of those who need it most.
Improved ED throughput
The Atellica VTLi system streamlines chest pain assessment, aiding in earlier disposition decisions for patients not having an MI and fast interventions for those who are.
Evidence-based, accurate performance
The Atellica VTLi system offers hs-cTnI testing right at the point of care. Results are available in just minutes for clinicians and laboratory partners.
Easily integrated into assessment processes
The Atellica VTLi system will aid in transforming your chest pain assessment process to benefit patients, clinicians, and operational workflow.
Assays
* for hs-cTnI
† This product is under development and not commercially available. Its future availability cannot be ensured.
Technical Details
Did this information help you?
* for hs-cTnI
† The products/features (mentioned herein) are not commercially available in all countries. Not available for sale in the U.S.A. Their future availability cannot be guaranteed.